HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 47, 39637-39643, November 25, 2005

This Article Abstract Full Text (PDF) Supplemental Data All Versions of this Article: 280/47/39637    most recent M509328200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Habibian, R. Articles by Dibrov, P. Search for Related Content PubMed PubMed Citation Articles by Habibian, R. Articles by Dibrov, P. Social Bookmarking                      What's this?

Functional Analysis of Conserved Polar Residues in Vc-NhaD, Na⁺/H⁺ Antiporter of Vibrio cholerae^*

Rahim Habibian, Judith Dzioba, Jeannie Barrett, Michael Y. Galperin1, Peter C. Loewen, and Pavel Dibrov2

From the Department of Microbiology, University of Manitoba, Winnipeg, Manitoba R3T 2N2, Canada and National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894

Received for publication, August 24, 2005 , and in revised form, September 23, 2005.

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Vc-NhaD is a Na⁺/H⁺ antiporter from Vibrio cholerae with a sharp maximum of activity at pH 8.0. NhaD homologues are present in many bacteria as well as in higher plants. However, very little is known about structure-function relations in NhaD-type antiporters. In this work 14 conserved polar residues associated with putative transmembrane segments of Vc-NhaD have been screened for their possible role in the ion translocation and pH regulation of Vc-NhaD. Substitutions S150A, D154G, N155A, N189A, D199A, T201A, T202A, S389A, N394G, S428A, and S431A completely abolished the Vc-NhaD-mediated Na⁺-dependent H⁺ transfer in inside-out membrane vesicles. Substitutions T157A and S428A caused a significant increase of apparent K_m values for alkali cations, with the K_m for Li⁺ elevated more than that for Na⁺, indicating that Thr-157 and Ser-428 are involved in alkali cation binding/translocation. Of six conserved His residues, mutation of only His-93 and His-210 affected the Na⁺(Li⁺)/H⁺ antiport, resulting in an acidic shift of its pH profile, whereas H93A also caused a 7-fold increase of apparent K_m for Na⁺ without affecting the K_m for Li⁺. These data suggest that side chains of His-93 and His-210 are involved in proton binding and that His-93 also contributes to the binding of Na ions during the catalytic cycle. These 15 residues are clustered in three distinct groups, two located at opposite sides of the membrane, presumably facilitating the access of substrate ions to the third group, a putative catalytic site in the middle of lipid bilayer. The distribution of these key residues in Vc-NhaD molecule also suggests that transmembrane segments IV, V, VI, X, XI, and XII are situated close to one another, creating a transmembrane relay of charged/polar residues involved in the attraction, coordination, and translocation of transported cations.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Sodium proton antiporters are universal secondary ion transporters in bacteria. Typically, they expel toxic Na⁺ and Li⁺ ions from the cytoplasm at the expense of the proton motive force, thus playing an important role in cytoplasmic Na⁺ and pH homeostasis and providing energy for Na⁺ symports (for review, see Refs. 1-4). The Na⁺/H⁺ antiport in a bacterial cell is often mediated by antiporters of different types working in concert. Major enterobacterial antiporters, Ec-NhaA (5) and Ec-NhaB (6), have been extensively characterized in Escherichia coli (see Refs. 7-19; for review also see Ref. 4, and for recent progress see Refs. 20-23). The genome of pathogenic Vibrio cholerae encodes as many as six putative structural genes of Na⁺/H⁺ antiporters (24). The physiological basis for such apparent redundancy could be in part explained by recent findings of additional, predominantly regulatory functions of certain bacterial Na⁺/H⁺ antiporters affecting processes such as antibiotic efflux (25), the transcription of the Pho operon (26), the initiation of sporulation (27), and endospore germination (28).

Studying Na⁺/H⁺ antiport in V. cholerae, we have cloned a new Na⁺/H⁺ antiporter from V. cholerae, Vc-NhaD, and expressed it in its functional form in the NhaANhaB strain of E. coli (29). A distinctive feature of Vc-NhaD is its pH dependence with a sharp maximum of activity at pH 8.0 (29-30). This distinguishes Vc-NhaD from other major enterobacterial antiporters. Indeed, Ec-NhaB from E. coli is pH-independent, whereas the activity of Ec-NhaA gradually increases upon pH shift from 7.0 to 8.0, reaching a plateau (9). Curiously, homologous NhaD from Vibrio parahaemolyticus exhibits pH dependence similar to Ec-NhaA rather than Vc-NhaD (31).

The Na⁺/H⁺ antiporters of NhaD type are widely distributed in nature, being found in genomes of pathogenic vibrios, nitrogen-fixing symbionts, magnetotactic cocci and photosynthetic bacteria as well as in higher plants (Fig. 1). In obligate intracellular parasites of Chlamydia genus, NhaD serves as a sole Na⁺/H⁺ antiporter (32-33). However, very little is known about the molecular mechanisms of cation exchange mediated by these proteins. In the absence of a detailed crystal structure, identification of functionally important residues in antiporters by site-directed mutagenesis remains one of the most informative approaches. Because Na⁺/H⁺ antiporters are exchanging cations, negatively charged residues are obvious primary targets for mutagenesis (see for example Refs. 18 and 23). In our previous work we found that mutation of three polar residues, Asp-344, Thr-345 (TMS³ X and loop IX-X), and Asp-393 (within TMS XI) severely affects the Na⁺-dependent proton transfer mediated by Vc-NhaD (30). In the present study we extended these observations by mutating Vc-NhaD residues that are conserved in NhaD homologues from different organisms (see Fig. 1). In particular, the following questions were addressed. (i) Are polar residues Ser-389, Ser-390, and Asn-394 surrounding Asp-393 in TMS XI functionally important as well? (ii) Do the distant conserved polar residues associated with TMS V and VI (Asp-154, Thr-157, Asp-199, Thr-201, Thr-202) affect the function of Vc-NhaD? (iii) Are any of the conserved His residues involved in the pH response of Vc-NhaD, such as His-225 in Ec-NhaA (15-16)? (iv) How would the substitution of all Cys residues by serines affect the activity?

Here we report the identification of three distinct clusters of functionally important polar residues dispersed through the protein. Cluster 1 is associated with TMS IV-VI at the periplasmic side of the protein, cluster 2 is at the opposite side facing cytoplasm (TMS X), and cluster 3 in TMS XI-XII is located in the middle of the transmembrane segments. Together with residues His-93 and His-210, which control the pH profile of the antiport and its affinity to alkali cations, these clusters may form a transmembrane relay of charged/polar residues involved in the attraction, coordination, and translocation of transported ions in a striking similarity to the recently reported structure of phylogenetically distant Ec-NhaA (22).

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Materials—All chemicals were from Fisher or Sigma. Restriction nucleases were from Invitrogen, MBI Fermentas, or New England Biolabs.

Bacterial Strains and Culture Conditions—The Na⁺/H⁺ antiporter-deficient (melBLid, NhaB1, cam^R, NhaA1, kan^R, lacZY, thr1) strain of E. coli, EP432 was kindly provided by Dr. E. Padan (Hebrew University of Jerusalem, Jerusalem, Israel). For routine cloning and plasmid construction, DH5 (United States Biochemical Corp.) was used as the host. If not indicated otherwise, cells were grown aerobically at 37 °C in modified L broth (LBK) in which NaCl was replaced by KCl (7). All transformants were grown in media supplemented with 100 µg/ml ampicillin.

Site-directed Mutagenesis—Site-directed mutagenesis was performed with the QuikChange site-directed mutagenesis kit (Stratagene) as recommended by the manufacturer. The mutagenic oligonucleotide primers were designed to create or remove specific restriction enzyme sites (listed in the supplemental table). As a template for mutagenesis, the plasmid pBLDL (pBluescript II KS+ (Stratagene) containing the nhaD gene together with the 300-bp-long 5'- and 230-bp-long 3'-flanking sequences as a 1837-bp EcoRI-BamHI insert) was used (29). Mutated plasmid DNA was isolated from selected transformant clones and digested by appropriate restriction enzymes to check for the presence of desired mutation. The minimal nhaD fragments containing the target mutation were then excised and used to replace the respective sequences in the original (non-mutated) pBLDL. Fidelity of all final mutated versions of nhaD in pBLDL was verified by DNA sequencing.

Isolation of Membrane Vesicles and Assay of Na⁺/H⁺ Antiport Activity—Inside-out membrane vesicles were obtained by passing a bacterial suspension through a French press (Aminco) and assayed for Na⁺/H⁺ antiport activity as described previously (29-30). Protein content in membrane vesicles was determined by the Bio-Rad detergent compatible protein assay kit. The Na⁺/H⁺ antiporter activity was registered by the acridine orange fluorescence dequenching. Aliquots of vesicles (200 µg of protein) were resuspended in 2 ml of a medium containing 100 mM KCl, 250 mM sucrose, 10 mM MgSO₄, 0.5 µM acridine orange, and 50 mM Hepes-Tris buffer adjusted to the indicated pH. Respiration-dependent formation of the pH was initiated by the addition of 10 mM Tris-D-lactate, and the resulting quenching of acridine orange fluorescence was monitored with the Shimadzu RF-1501 spectrofluorophotometer (excitation at 492 nm and emission at 528 nm). Na⁺/H⁺ antiporter activity was estimated based on its ability to dissipate the established pH upon the addition of the indicated concentrations of NaCl or LiCl (10 mM in the pH-profile determination; 0.5-50 mM for the determination of half-maximal effective concentration). The antiport activities are expressed as percent restoration of the lactate-induced fluorescence quenching.

In Silico Analysis of Vc-NhaD—NhaD homologues in various organisms were identified through a BLASTP (34) search against the NCBI (Bethesda, MD) nonredundant protein database. A partial alignment showing the conserved polar residues located within or associated with putative transmembrane segments as well as conserved His and Cys residues is shown in Fig. 1. Putative membrane topology model of NhaD from V. cholerae (Fig. 1B) was constructed using the Topopredict II (35) and HMMTOP (36) programs. The three-dimensional diagram showing the recently reported structure of Ec-NhaA (22) in relation to the functionally important residues of Vc-NhaD was prepared using VMD (44).

Immunodetection of Vc-NhaD in Membranes—Polyclonal anti-NhaD antibodies were produced by Genemed Synthesis, Inc. against the following peptide from a putative IX-X loop of Vc-NhaD: ³¹⁶AKNDEAALKRIGSVVPFDVFRSISHAC³⁴² (with C-terminal cysteine added for coupling). The antibodies were further affinity-purified on the column containing the above peptide coupled to SulfoLink coupling gel (Pierce). The procedure recommended by the manufacturer was followed with a minor modification; the antibodies were eluted in 0.5-ml fractions into Eppendorf tubes containing 50 µl of glycerol and 50 µl of 1 M Tris-HCl, pH 7.5, to prevent antibody precipitation.

To deplete proteins loosely bound to the membranes, aliquots of membrane vesicles containing 100 µg of total membrane protein were carbonate-extracted by the incubation on ice for 15 min in 200 µl of 0.1 M sodium carbonate. The samples were then pelleted by ultracentrifugation at 100,000 rpm in TLA100.3 Beckman rotor for 30 min. The membrane pellets were re-suspended in 200 µl of a standard SDS-PAGE loading buffer each and incubated at 42 °C for 30 min with shaking. For electrophoresis, 20 µl of sample was loaded per lane. Proteins were resolved in 12% polyacrylamide gel and transferred onto a polyvinylidene difluoride Western blotting membrane (Roche Applied Science). The membranes were blocked at room temperature with 10% skim milk powder dissolved in PBS with 1% Tween 20 (Sigma) (PBST) for 30 min. Then the membrane was incubated with the affinity-purified anti-NhaD antibodies at a dilution of 1:3000 in 2% skim milk powder dissolved in PBST. The blot was rinsed 5 times for 5 min each with PBST and incubated for 30 min with goat anti-rabbit IgG horseradish peroxidase conjugate (Bio-Rad) at a dilution of 1:3000 in 2% skim milk powder dissolved in PBST. The blot was rinsed 5 times for 5 min each with PBST. Immunoreactive proteins were visualized using the Amersham enhanced chemiluminescence kit as recommended by the manufacturer. A Fluoro Chem^TM 8900 was used to detect the resulting signal.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Strategy of Mutagenesis—Fig. 1A illustrates the strategy adopted for choosing the target amino acids for mutagenesis. It shows partial alignments of representative NhaD-like proteins from different organisms. Sequences presented in Fig. 1A may be divided into three subgroups, with proteins within subgroups sharing higher degrees of identity/similarity. The largest one includes NhaD-like proteins from bacteria that are free-living or have a free-living stage in their life cycle (Subgroup 1, last seven rows in Fig. 1A). Chlamydial proteins (from obligate intracellular parasites, rows three and four in Fig. 1) comprise the second subgroup (Subgroup 2). The third subgroup includes NhaD from nitrogen-fixing symbiont Bradyrhizobium japonicum and higher plant Arabidopsis thaliana.

Thirteen polar/charged residues are conserved in all aligned sequences (highlighted and marked by asterisks in Fig. 1). In Vc-NhaD these residues are Ser-150, Asp-154, Asn-155, Thr-157, Asn-189, Asp-199, Thr-201, Thr-202, Ser-389, Asp-393, Asn-394, Ser-425, and Ser-431. From this list we had previously mutagenized Asp-393 (30) in a study that also included Glu-100, Glu-342, Asp-344, and Thr-345, which are conserved in antiporters belonging to Subgroup 1 as well as the weakly conserved Glu-251. The remaining residues were investigated in this study. Routinely, a target residue was changed into Ala, except Asp-154 and Asn-394, which were changed into Gly. Because our aim was to eliminate charged side chains in chosen positions, either substitution seemed appropriate. Choice of Gly in two mentioned cases just simplified the screening of mutant clones by restriction analysis.

View larger version (60K): [in this window] [in a new window]   FIGURE 1. In silico analysis of Vc-NhaD. A, partial alignments of representative NhaD proteins. Amino acid sequence of the protein from A. thaliana (Ath, accession number AAG51773 [GenBank] ) was used as a query for BLAST. The sequences used were found in Microbulbifer degradans (Md, ZP_00064921), Rhodobacter sphaeroides (Rsp, ZP_00007535), Shewanella oneidensis (Son, AAN54009 [GenBank] ), V. cholerae (Vc, AAF96911 [GenBank] ), V. parahemeolyticus (Vp, BAC61394 [GenBank] ), Vibrio vulnificus (Vv, AAO08110 [GenBank] ), Magnetococcus sp. (Mg, ZP_00288831), Chlamyidophila pneumoniae (Cpn, BAA99222 [GenBank] ), Chlamydia trachomatis (Ctr, AAC68454 [GenBank] ), and B. japonicum (Bja, NP_770379 [GenBank] ). Conserved residues targeted for mutagenesis in Vc-NhaD are underlined; the asterisks (*) indicates polar residues conserved in all aligned sequences. Numbers 1, 2, and 3 on the right side indicate 3 subgroups of proteins sharing a high degree of identity/similarity (see the text for further details). B, distribution of probed residues in the putative transmembrane segments of Vc-NhaD molecule. Conserved residues were generally mutated into alanines, excluding Asp-154 and Asn-394, which were mutated into glycines. Cys-163, Cys-181, and Cys-355 were substituted by serine residues. Strongly conserved residues (that is, conserved in all sequences aligned in Fig. 1) are given in boldface. Shown also are functionally important residues Asp-344, Thr-345, and Asp-393 characterized previously (28).

View larger version (10K): [in this window] [in a new window]   FIGURE 2. Cys-less variant of Vc-NhaD retains the activity and pH profile of the wild type antiporter. Sub-bacterial vesicles from EP432 cells expressing either non-mutated Vc-NhaD (open symbols) or its Cys-less variant (closed symbols) were isolated as described under "Experimental Procedures" and assayed at different pH with 10 mM NaCl (circles) or 10 mM LiCl (squares). Experiments were repeated at least three times, and results were nearly identical.

Mutagenesis of Conserved His Residues—Fig. 3 summarizes the results of substituting the conserved His residues in Vc-NhaD with Ala. In inside-out sub-bacterial vesicles, H274A, H278A, H450A, and H468A did not change the Na⁺(Li⁺)/H⁺ antiport activity significantly, but H93A and H210A variants displayed an acidic shift of the pH profile of the antiport for both alkali cations (Fig. 3). The shift was more pronounced in the H93A variant, which also responded differently to Na⁺ and Li⁺ ions, showing higher activity with Li⁺ (Fig. 3). To further assess the affinity of H93A and H210A variants to alkali cations, the concentrations of Na⁺ and Li⁺ required for half-maximal response (apparent K_m values) at pH 7.75 were determined in sub-bacterial vesicles (TABLE ONE). Despite the fact that apparent K_m is only indirectly related to the actual K_m of the antiporter, this readily measurable parameter is commonly used to characterize antiporter affinity to substrate ions (for example, see Ref. 14). Here again the apparent K_m of H93A for Na⁺ was 7-fold higher than in the wild type, whereas its apparent K_m for Li⁺ was unaffected (TABLE ONE). By contrast, there was only a slight increase in the apparent K_m of H210A for Li⁺ (TABLE ONE).

View larger version (33K): [in this window] [in a new window]   FIGURE 3. Effect of His Ala substitutions on the pH profile of activity of Vc-NhaD. Experimental conditions are as in Fig. 2. Activity of the wild type (WT) Vc-NhaD with 10 mM NaCl is shown for the reference (empty circles). All measurements were repeated at least three times, and results were essentially the same.

Expression/Targeting of Vc-NhaD Variants—Because a number of Vc-NhaD variants were unable to complement the EP432 and catalyze Na⁺ (Li⁺)-dependent H⁺ phenotype transfer in sub-bacterial vesicles, levels of their expression in the EP432 membranes were examined by Western blotting. It confirmed that the mutations generally did not interfere with either the expression or targeting to the membrane (Fig. 5). Expression levels of all inactive variants in EP432 except S431A were comparable with that of the wild type protein, and even for S431A the slightly reduced levels cannot account for the complete absence of activity.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
The present study is the first to provide an extensive molecular analysis of a Na⁺/H⁺ antiporter of the NhaD type. General methodology of the analysis of mutant variants of Na⁺/H⁺ antiporters has been developed over the past decade, primarily in works by Padan and co-workers (see, for example, Refs. 20 and 37). This methodology allows the differentiation among residues that regulate the pH response of an antiporter and those involved in the translocation of cations. The former residues are expected to (i) have a pK in the physiological pH range, (ii) change the pH profile of antiport when mutated without an effect on the K_m of antiport, and (iii) maintain the altered pH profile of a mutant variant assayed at saturating concentrations of substrate alkali cations. In terms of function, such residues could form an allosteric "built-in pH sensor" (20, 37) or belong to the intramolecular H⁺ translocation pathway. The latter residues should (i) be associated with transmembrane segments, (ii) be able to interact with translocated cations, and (iii) affect the K_m of antiport when mutated without affecting the wild type pH profile, at least at saturating concentrations of alkali cations. Obviously, such residues could affect ion translocation either directly (i.e. by providing ligands for the coordination of transported cations) or indirectly (being important for the overall protein structure or conformational changes associated with ion translocation without direct interaction with substrate cations). Finally, some residues might be involved in both the pH response and ion translocation, for example if protons and alkali cations share at least some segments of the same translocation pathway.

View larger version (30K): [in this window] [in a new window]   FIGURE 4. The pH profiles of different variants of Vc-NhaD determined in everted sub-bacterial vesicles of EP432 expressing the corresponding variant. Experimental conditions are as in Fig. 2. T201A, S431A, and S425A exemplify mutations such as S150A, D154G, N155A, T202A, D199A, S389A, and N394G that resulted in a complete arrest of the Na+-dependent H+ transfer in vesicles over the pH range 6.6-9.0. All experiments were repeated at least three times, and results were nearly identical. WT, wild type.

View larger version (21K): [in this window] [in a new window]   FIGURE 5. Immunodetection of different variants of Vc-NhaD in the membranes of EP432. Neither mutation prevented the expression and targeting of the antiporter. The level of the expression of T202A variant was very similar to that of T201A (not shown). Western blot analysis with affinity purified polyclonal anti-Vc-NhaD antibodies was performed as described under "Experimental Procedures."

Charged/polar residues associated with TMSs have been implicated in the ion translocation mediated by a variety of Na⁺-dependent transporters. The Na⁺-binding sites of the Na⁺ motive ATPases from Propionigenium modestum and Acetobacterium woodii are thought to be formed by closely positioned conserved Asp, Thr, and Asn residues (38-39). Hydroxyl groups provided by Ser and Thr residues are critical for activity of such diverse Na⁺-motive proteins as the proline transporter in E. coli (40), the Na⁺-dependent oxaloacetate decarboxylase (41), the Na⁺/iodide symporter (42), and the glutamate transporter GLT-1 (43). Most importantly, recent analysis of the structure of Ec-NhaA clearly shows that Asp-163, Asp-164, site and Thr-132 are parts of the catalytic in this bacterial Na⁺/H⁺ antiporter (22). Two residues definitely involved in the alkali cation binding and/or translocation, Thr-157 and Ser-428, are located in the TMSs V and XII, respectively (Fig. 1B), and variants of both show markedly lower affinity to Li⁺ compared with Na⁺ (Fig. 4 and TABLE ONE), supporting the idea of Li⁺ having more stringent structural requirements for binding to the antiporter.

Functionally important amino acids identified in Vc-NhaD form three major clusters (Fig. 1B). Cluster 1 includes Ser-150, Asp-154, Asn-155, Thr-157, Asp-199, Thr-201, and Thr-202 in neighboring TMS IV, V, and VI. Cluster 2, presumably located at the opposite side of the transmembrane segments, includes Asp-344 and Thr-345 in TMS X (30). Finally, Cluster 3, located in the middle of TMSs XI-XII, includes Ser-389, Asp-393, Asn-394, S425, Ser-428, and Ser-431. This distribution presents distinct parallels to the recently reported structure of Ec-NhaA resolved at 3.45 Å (22), which provides important insights into function of bacterial Na⁺/H⁺ antiporters. In particular, a negatively charged funnel with Glu-78, Glu-82, Glu-252, and Asp-11 at its entrance leads from the cytoplasm to a putative catalytic site in the middle of the membrane containing the charged/polar residues Asp-163, Asp-164, Thr-132, and Asp-133. On the opposite side of the protein, a shallow, negatively charged funnel with Asp-65 at its tip connects the periplasm to the central cation-binding site (22). The arrangement allows for the access of substrate ions through the funnels to the catalytic site, which could operate in the alternating-access mode (22). It is tempting to speculate that phylogenetically unrelated Vc-NhaD shares these structural elements. Cluster 1 in TMSs IV-VI together with His-93 and His-210 may represent an analog of the shallow negatively charged funnel on the periplasmic side of Ec-NhaA, attracting cations toward the putative catalytic site in the middle of the protein made up of Cluster 2 in TMSs XI and XII. Of note, five or six oxygen ligands are required to coordinate an alkali cation (46-47) and residues of Cluster 2, Ser-389, Asp-393, S425, Ser-428, and Ser-431 will suffice in this respect. Finally, the pair of Asp-344 and Thr-345 on TMS X and Asn-189 of TMS VI may be part of the funnel that facilitates the ion access from the cytoplasmic side. Thus, despite their distant phylogenetic relationships, different groups of bacterial Na⁺/H⁺ antiporters may share common structural features and catalytic mode. Possible similarities between Ec-NhaA and Vc-NhaD outlined above are summarized in Fig. 6. It should be stressed here though that a crystal structure of Vc-NhaD is required to determine the location of each residue.

View larger version (32K): [in this window] [in a new window]   FIGURE 6. Possible analogies between functionally important residues in Ec-NhaA and Vc-NhaD. The structure of Ec-NhaA is shown on the left along with a listing of conserved residues known to have a role in antiport. A listing of residues from Vc-NhaD in equivalent positions is included on the right. In both cases a group of negatively charged/polar residues in the middle of the structure might form the putative cationbinding site with two other groups at opposite sides facilitating the access of ions to this active site.

The distribution of functionally important residues in the Vc-NhaD molecule suggests that two groups of transmembrane segments, TMSs IV-VI and TMSs X-XII, may be located close to one another. Because the Cys-less variant of Vc-NhaD is fully active (Fig. 2), the helical packing of Vc-NhaD as well as the precise membrane topology of the anti-porter may be probed by Cys-scanning mutagenesis. In particular, introducing pairs of Cys residues at appropriate locations and applying different cross-linking reagents, one may estimate the distances between TMSs of interest. This work is currently under way.

	FOOTNOTES

 
^* This research was supported by grants from Natural Sciences and Engineering Research Council of Canada (to P. C. L., P. D., R. H., and J. D.) and the Canada Research Chair Program (to P. C. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains a supplemental table.

¹ Supported by the Intramural Research Program at the National Library of Medicine, National Institutes of Health.

² To whom correspondence should be addressed: Dept. of Microbiology, University of Manitoba, Fort Garry campus, Rm. 425 Buller Bldg., Winnipeg, Manitoba R3T 2N2 Canada. Tel.: 204-474-8059; Fax: 204-474-7603; E-mail: dibrovp{at}ms.umanitoba.ca.

³ The abbreviations used are: TMS, transmembrane segment; Ec-NhaA and Ec-NhaB, Na⁺/H⁺ antiporters of NhaA type and NhaB type from E. coli, respectively; Vc-NhaD, Na⁺/H⁺ antiporter of NhaD type from V. cholerae; pH, pH difference across the membrane; PBS, phosphate-buffered saline.

⁴ J. Dzioba, unpublished observation.

	ACKNOWLEDGMENTS

 
Many thanks are due to Dr. T. A. Krulwich for critical reading of the manuscript and valuable suggestions.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Busch W., and Saier, M. H., Jr. (2002) Crit. Rev. Biochem. Mol. Biol. 37, 287-337[CrossRef][Medline] [Order article via Infotrieve]
2. Padan, E., and Schuldiner, S. (1992) in Alkali Cation Transport Systems in Procaryotes (Bakker, E., ed) pp. 3-24, CRC Press, Inc., Boca Raton, FL
3. Padan, E., and Schuldiner, S. (1994) Biochim. Biophys. Acta 1185, 129-151[Medline] [Order article via Infotrieve]
4. Padan, E., Venturi, M., Gerchman, Y., and Dover, N. (2001) Biochim. Biophys. Acta 1505, 144-157[Medline] [Order article via Infotrieve]
5. Goldberg, B. G., Arbel, T., Chen, J., Karpel, R., Mackie, G. A., Schuldiner, S., and Padan, E. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 2615-2619[Abstract/Free Full Text]
6. Pinner, E., Padan, E., and Schuldiner, S. (1992) J. Biol. Chem. 267, 11064-11068[Abstract/Free Full Text]
7. Padan, E., Maisler, N., Taglicht, D., Karpel, R., and Schuldiner, S. (1989) J. Biol. Chem. 264, 20297-20302[Abstract/Free Full Text]
8. Pinner, E., Kotler, Y., Padan, E., and Schuldiner, S. (1993) J. Biol. Chem. 268, 1729-1734[Abstract/Free Full Text]
9. Taglicht, D., Padan, E., and Schuldiner, S. (1991) J. Biol. Chem. 266, 11289-11294[Abstract/Free Full Text]
10. Pinner, E., Padan, E., and Schuldiner, S. (1994) J. Biol. Chem. 269, 26274-26279[Abstract/Free Full Text]
11. Taglicht, D., Padan, E., and Schuldiner, S. (1993) J. Biol. Chem. 268, 5382-5387[Abstract/Free Full Text]
12. Dibrov, P., and Taglicht, D. (1993) FEBS Lett. 336, 525-529[CrossRef][Medline] [Order article via Infotrieve]
13. Dibrov, P. (1993) FEBS Lett. 336, 530-534[CrossRef][Medline] [Order article via Infotrieve]
14. Gerchman, Y., Rimon, A., Venturi, M., and Padan, E. (2001) Biochemistry 40, 3403-3412[CrossRef][Medline] [Order article via Infotrieve]
15. Gerchman, Y., Olami, Y., Rimon, A., Taglicht, D., Schuldiner, S., and Padan, E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1212-1216[Abstract/Free Full Text]
16. Rimon, A., Gerchman, Y., Olami, Y., Schuldiner, S., and Padan, E. (1995) J. Biol. Chem. 270, 26813-26817[Abstract/Free Full Text]
17. Olami, Y., Rimon, A., Gerchman, Y., Rothman, A., and Padan, E. (1997) J. Biol. Chem. 272, 1761-1768[Abstract/Free Full Text]
18. Inoue, H., Noumi, T., Tsuchiya, T., and Kanazawa, H. (1995) FEBS Lett. 363, 264-268[CrossRef][Medline] [Order article via Infotrieve]
19. Noumi, T., Inoue, H., Sakurai, T., Tsuchiya, T., and Kanazawa, H. (1997) J. Biochem. 121, 661-670[Abstract/Free Full Text]
20. Galili, L., Rothman, A., Kozachkov, L., Rimon, A., and Padan, E. (2002) Biochemistry 41, 609-617[CrossRef][Medline] [Order article via Infotrieve]
21. Rimon, A., Tzubery, T., Galili, L., and Padan, E. (2002) Biochemistry 41, 14897-14905[CrossRef][Medline] [Order article via Infotrieve]
22. Hunte, C., Screpanti, E., Venturi, M., Rimon, A., Padan, E., and Michel, H. (2005) Nature 435, 1197-1202[CrossRef][Medline] [Order article via Infotrieve]
23. Tzuberi, T., Rimon, A., and Padan, E. (2004) J. Biol. Chem. 279, 3265-3272[Abstract/Free Full Text]
24. Heidelberg, J. F., et al. (2000) Nature 406, 477-483[CrossRef][Medline] [Order article via Infotrieve]
25. Krulwich, T. A., Jin, J., Guffanti, A. A., and Bechhofer, D. H. (2001) J. Mol. Microbiol. Biotechnol. 3, 237-246[Medline] [Order article via Infotrieve]
26. Pragai, Z., Eschevins, C., Bron, S., and Harwood, C. R. (2001) J. Bacteriol. 183, 2505-2515[Abstract/Free Full Text]
27. Kosono, S., Ohashi, Y., Kawamura, F., Kitada, M., and Kudo, T. (2000) J. Bacteriol. 182, 898-904[Abstract/Free Full Text]
28. Southworth, T. W., Guffanti, A. A., Moir, A., and Krulwich, T. A. (2001) J. Bacteriol. 183, 5896-5903[Abstract/Free Full Text]
29. Dzioba, J., Ostroumov, E., Winogrodzki, A., and Dibrov, P. (2001) Mol. Cell. Biochem. 229, 119-124
30. Ostroumov, E., Dzioba, J., Loewen, P. C., and Dibrov, P. (2002) Biochim. Biophys. Acta 1564, 99-106[Medline] [Order article via Infotrieve]
31. Nozaki, K., Kuroda, T., Mizushima, T., and Tsuchiya, T. (1998) Biochim. Biophys. Acta 1369, 213-220[Medline] [Order article via Infotrieve]
32. Häse, C., Fedorova, N., Galperin, M. Y., and Dibrov, P. (2001) Microbiol. Mol. Biol. Rev. 65, 353-370[Abstract/Free Full Text]
33. Dibrov, P., Dibrov, E., Pierce, G. N., and Galperin, M. Y. (2004) J. Mol. Microbiol. Biotechnol. 8, 1-6[CrossRef][Medline] [Order article via Infotrieve]
34. Altschul, S., Madden, T., Schaffer, A., Zhang, J., Zheng, Z., Miller, W., and Lipman, D. (1997) Nucleic Acids Res. 25, 3389-3402[Abstract/Free Full Text]
35. Claros, M., and von Heijne, G. (1994) Comput. Appl. Biosci. 10, 685-686[Free Full Text]
36. Tusnády, G. E., and Simon, I. (1998) J. Mol. Biol. 283, 489-506[CrossRef][Medline] [Order article via Infotrieve]
37. Padan, E., Tzubery, T., Herz, K., Kozachkov, L., Rimon, A., and Galili, L. (2004) Biochim. Biophys. Acta 1658, 2-13[Medline] [Order article via Infotrieve]
38. Kaim, G., Wehrle, F., Gerike, U., and Dimroth, P. (1997) Biochemistry 36, 9185-9194[CrossRef][Medline] [Order article via Infotrieve]
39. Rahlfs, S. M. V. (1997) FEBS Lett. 404, 269-271[CrossRef][Medline] [Order article via Infotrieve]
40. Quick, M., Tebbe, S., and Jung, H. (1996) Eur. J. Biochem. 239, 732-736[Medline] [Order article via Infotrieve]
41. Jockel, P., Schmid, M., Steuber, J., and Dimroth, P. (2000) Biochemistry 39, 2307-2315[CrossRef][Medline] [Order article via Infotrieve]
42. De La Vieja, A., Dohan, O., Levy, O., and Carrasco, N. (2000) Physiol. Rev. 80, 1083-1105[Abstract/Free Full Text]
43. Zhang, Y., and Kanner, B. I. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 1710-1715[Abstract/Free Full Text]
44. Humphrey, W., Dalke, A., and Schulten, K. (1996) J. Mol. Graph. 14, 33-38[CrossRef][Medline] [Order article via Infotrieve]
45. Rimon A., Gerchman Y., Kariv Z., and Padan, E. (1998) J. Biol. Chem. 273, 26470-26476[Abstract/Free Full Text]
46. Glusker, G. P. (1991) Adv. Protein Chem. 42, 1-76[Medline] [Order article via Infotrieve]
47. Harding, M. M. (2004) Acta Crystallogr. D Biol. Crystallogr. 60, 849-859[CrossRef][Medline] [Order article via Infotrieve]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Barrero-Gil, A. Rodriguez-Navarro, and B. Benito Cloning of the PpNHAD1 transporter of Physcomitrella patens, a chloroplast transporter highly conserved in photosynthetic eukaryotic organisms J. Exp. Bot., August 1, 2007; 58(11): 2839 - 2849. [Abstract] [Full Text] [PDF]

				E. Olkhova, C. Hunte, E. Screpanti, E. Padan, and H. Michel Multiconformation continuum electrostatics analysis of the NhaA Na+/H+ antiporter of Escherichia coli with functional implications PNAS, February 21, 2006; 103(8): 2629 - 2634. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Supplemental Data All Versions of this Article: 280/47/39637    most recent M509328200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Habibian, R. Articles by Dibrov, P. Search for Related Content PubMed PubMed Citation Articles by Habibian, R. Articles by Dibrov, P. Social Bookmarking                      What's this?